Title |
Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells
|
---|---|
Published in |
Experimental Hematology & Oncology, March 2014
|
DOI | 10.1186/2162-3619-3-9 |
Pubmed ID | |
Authors |
Christian S Rogers, Clement G Yedjou, Dwayne J Sutton, Paul B Tchounwou |
Abstract |
Arsenic trioxide (ATO) is a novel form of therapy that has been found to aid acute promyelocytic leukemia (APL) patients. Our laboratory has demonstrated that ATO-induced cytotoxicity in human leukemia (HL-60) cells is mediated by oxidative stress. Pro-oxidants have been known to play a role in free radical-mediated oxidative stress. Vitamin D3, (Vit D3) an active metabolite of vitamin D has been reported to inhibit the growth of number neoplasms such as prostate, breast, colorectal, leukemia, and skin cancers. The goal of the present research was to use (HL-60) cells as an in vitro test model to evaluate whether low doses of Vit D3 potentiate the toxicity of ATO and whether this toxic action is mediated via apoptotic mechanisms. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 30 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 19% |
Student > Bachelor | 4 | 13% |
Student > Ph. D. Student | 4 | 13% |
Professor > Associate Professor | 4 | 13% |
Student > Master | 2 | 6% |
Other | 4 | 13% |
Unknown | 7 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 19% |
Medicine and Dentistry | 5 | 16% |
Agricultural and Biological Sciences | 5 | 16% |
Immunology and Microbiology | 2 | 6% |
Chemical Engineering | 1 | 3% |
Other | 3 | 10% |
Unknown | 9 | 29% |